Advanced

Serological markers predict inflammatory bowel disease years before the diagnosis

van Schaik, Fiona D. M.; Oldenburg, Bas; Hart, Andrew R.; Siersema, Peter D.; Lindgren, Stefan LU ; Grip, Olof LU ; Teucher, Birgit; Kaaks, Rudolf; Bergmann, Manuela M. and Boeing, Heiner, et al. (2013) In Gut 62(5). p.683-688
Abstract
Objective Anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies (ASCAs) have been detected in the serum of patients with ulcerative colitis (UC) and Crohn's disease (CD) and their unaffected family members. The aim of this study was to establish the value of serological markers as predictors of UC and CD. Design Individuals who developed CD or UC were identified from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. At recruitment, none of the participants had a diagnosis of CD or UC. For each incident case, two controls were randomly selected matched for centre, date of birth, sex, date of recruitment and time of follow-up. Serum of cases and controls obtained at... (More)
Objective Anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies (ASCAs) have been detected in the serum of patients with ulcerative colitis (UC) and Crohn's disease (CD) and their unaffected family members. The aim of this study was to establish the value of serological markers as predictors of UC and CD. Design Individuals who developed CD or UC were identified from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. At recruitment, none of the participants had a diagnosis of CD or UC. For each incident case, two controls were randomly selected matched for centre, date of birth, sex, date of recruitment and time of follow-up. Serum of cases and controls obtained at recruitment were analysed for ASCA IgG, ASCA IgA, perinuclear anti-neutrophil cytoplasmic antibody (pANCA), antibodies against Escherichia coli outer membrane porin C (OmpC) and flagellin CBir1. Conditional logistic regression was used to determine risk of CD and UC. Receiver operating characteristic curves were constructed to test accuracy. Results A total of 77 individuals were diagnosed with CD and 167 with UC after a mean follow-up of 4.5 (SD 3.2) and 4.4 (SD 3.1) years following blood collection, respectively. Combinations of pANCA, ASCA, anti-CBir1 and anti-OmpC were most accurate in predicting incident CD and UC (area under curve 0.679 and 0.657, respectively). The predictive value of the combination of markers increased when time to diagnosis of CD or UC decreased. Conclusion A panel of serological markers is able to predict development of CD and UC in individuals from a low-risk population. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Gut
volume
62
issue
5
pages
683 - 688
publisher
BMJ Publishing Group
external identifiers
  • wos:000316990200006
  • scopus:84875840665
ISSN
1468-3288
DOI
10.1136/gutjnl-2012-302717
language
English
LU publication?
yes
id
d78859c5-337d-4c8a-a88d-164515ca0c94 (old id 3748296)
date added to LUP
2013-06-03 08:35:35
date last changed
2019-02-17 04:05:02
@article{d78859c5-337d-4c8a-a88d-164515ca0c94,
  abstract     = {Objective Anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies (ASCAs) have been detected in the serum of patients with ulcerative colitis (UC) and Crohn's disease (CD) and their unaffected family members. The aim of this study was to establish the value of serological markers as predictors of UC and CD. Design Individuals who developed CD or UC were identified from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. At recruitment, none of the participants had a diagnosis of CD or UC. For each incident case, two controls were randomly selected matched for centre, date of birth, sex, date of recruitment and time of follow-up. Serum of cases and controls obtained at recruitment were analysed for ASCA IgG, ASCA IgA, perinuclear anti-neutrophil cytoplasmic antibody (pANCA), antibodies against Escherichia coli outer membrane porin C (OmpC) and flagellin CBir1. Conditional logistic regression was used to determine risk of CD and UC. Receiver operating characteristic curves were constructed to test accuracy. Results A total of 77 individuals were diagnosed with CD and 167 with UC after a mean follow-up of 4.5 (SD 3.2) and 4.4 (SD 3.1) years following blood collection, respectively. Combinations of pANCA, ASCA, anti-CBir1 and anti-OmpC were most accurate in predicting incident CD and UC (area under curve 0.679 and 0.657, respectively). The predictive value of the combination of markers increased when time to diagnosis of CD or UC decreased. Conclusion A panel of serological markers is able to predict development of CD and UC in individuals from a low-risk population.},
  author       = {van Schaik, Fiona D. M. and Oldenburg, Bas and Hart, Andrew R. and Siersema, Peter D. and Lindgren, Stefan and Grip, Olof and Teucher, Birgit and Kaaks, Rudolf and Bergmann, Manuela M. and Boeing, Heiner and Carbonnel, Franck and Jantchou, Prevost and Boutron-Ruault, Marie-Christine and Tjonneland, Anne and Olsen, Anja and Crowe, Francesca L. and Peeters, Petra H. M. and van Oijen, Martijn G. H. and Bueno-de-Mesquita, H. Bas},
  issn         = {1468-3288},
  language     = {eng},
  number       = {5},
  pages        = {683--688},
  publisher    = {BMJ Publishing Group},
  series       = {Gut},
  title        = {Serological markers predict inflammatory bowel disease years before the diagnosis},
  url          = {http://dx.doi.org/10.1136/gutjnl-2012-302717},
  volume       = {62},
  year         = {2013},
}